What Cryotec Global does

Cryotec Global, operating commercially as REPROLIFE Inc., is a Japanese-based company that develops and commercializes vitrification and warming technology for oocyte and embryo cryopreservation in the assisted reproductive technology (ART) market. Its core technology is built on proprietary vitrification/warming protocols originated by Dr. Masashige Kuwayama, and is delivered through a tiered product line: the original Cryotec system, a Ready-to-Use (RtU) consumable variant launched in September 2022, and Cryotec Pro, a premium upgrade launched at ESHRE 2025 in June 2025. The company also publishes comparative clinical evidence, most notably a study reporting a 52.55% pregnancy rate versus 48.99% for a competing brand across 1,041 embryos at 13 Japanese clinics.

The company operates a B2B go-to-market model, selling devices and consumables to fertility clinics worldwide, with stated distribution or commercial coverage across seven major global regions. Its commercial motion is heavily conference-driven, with recurring presence at ESHRE, ASRM, and MEFS, and an explicit "Challenge 100" clinic-acquisition initiative suggesting an active push to broaden adoption. There is no disclosed revenue, funding, headcount, M&A activity, or senior leadership change, and no AI/ML components are integrated into the product offering. The commercial story is therefore one of a focused, founder-led ART consumables/device vendor expanding product tier and international reach on a relatively narrow financial footprint.

Name

Cryotec Global

Legal name

Reprolife Inc.

Website

https://cryotec.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Cryotec Global (DBA: REPROLIFE Inc.) is a Japanese company that develops vitrification and warming technology for oocyte and embryo cryopreservation, selling a tiered Cryotec product line directly to fertility clinics worldwide.

Ownership category

akta.pro rank

Product category

Reproductive Medicine Cryopreservation

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

akta.pro secondary industries

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

• Vitrification solutions
• Embryo cryopreservation
• Oocyte freezing kits
• IVF lab products
• ART cryopreservation

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Cryotec Product Sales: Sale of Cryotec vitrification and warming products including Ready to Use kits, to fertility clinics and embryology laboratories worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Cryotec Global develops and sells proprietary vitrification and warming kits for the cryopreservation of oocytes and embryos used by fertility clinics, IVF centers, and embryology laboratories. Its flagship Cryotec Ready to Use (RtU) line features pre-dispensed, low-toxicity cryoprotectant solutions and a unified protocol applicable to cells of any stage, with clinical data demonstrating higher pregnancy rates than competing products.

Product overview

Cryotec Global, through its brand Reprolife, offers a unified product portfolio centered on the Cryotec vitrification and warming method for reproductive cells. The core offering includes the Cryotec method/product line, Cryotec Ready to Use (RtU) kits with pre-dispensed solutions, and Cryotec Pro. These products share a unified protocol that applies to oocytes and embryos at any stage, featuring simplified procedures and high survival rates. The portfolio is designed to serve embryologists in fertility clinics worldwide, with clinical validation data demonstrating superior pregnancy outcomes compared to competing solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Cryotec RtU: Cryotec Ready to Use - vitrification and warming kits for oocytes and embryos featuring pre-dispensed solutions and simplified protocols.
• Cryotec Pro

Products and services

• Cryotec Cryotec is an innovative vitrification and warming method and product line for oocytes and embryos, featuring simplified protocols, embryologist-friendly product designs, and a unified protocol applicable to cells of any stage. It is developed for fertility clinics and embryology laboratories.
• Cryotec Ready to Use (RtU) Cryotec Ready to Use is a pre-dispensed vitrification and warming kit that eliminates the need for manual solution preparation. Clinical data from 13 clinics in Japan (September 2022 - April 2024) demonstrated a 52.55% pregnancy rate compared to 48.99% with competing products, a 3.56 percentage point improvement. It targets fertility clinics, IVF centers, and embryology laboratories.
• Cryotec Pro Cryotec Pro is an advanced Cryotec product line for reproductive cryopreservation, announced and showcased at ESHRE 2025 in Paris. Specific features and capabilities were not detailed in the source material.

Quantifiable outcome

• Cryotec Ready to Use achieved 52.55% pregnancy rate vs 48.99% for competing brand (3.56 percentage point improvement) in study of 1,041 embryos across 13 Japanese clinics

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• FUJIFILM Irvine Scientific: Major manufacturer of IVF/ART media, including cryopreservation solutions, as part of a much broader cell culture and bioprocessing portfolio. Competes with Cryotec in vitrification media while serving adjacent markets with greater scale.
• CooperSurgical: Large women's health and fertility company offering ART consumables, devices, and genomics services to clinics globally. Overlaps with Cryotec in fertility clinic consumables but operates as a broad incumbent across multiple reproductive medicine categories.
• Cook Medical: Large medical device manufacturer with a reproductive health division offering ART products including cryopreservation devices. Broad incumbent serving fertility clinics alongside many other medical specialties, competing with Cryotec in select ART device categories.

Emerging players

• Rocket Medical: UK-based manufacturer of ART devices and consumables including embryo transfer and cryopreservation products. Comparable as a niche ART equipment supplier targeting the same fertility clinic customer base with adjacent device offerings.

Direct peers

• Hamilton Thorne: Provider of precision instruments, consumables, and software for the ART and reproductive medicine market. Overlaps with Cryotec in serving embryologists and IVF clinics with workflow tools, though more focused on laser and imaging instruments.
• Kitazato Corporation: Japan-based developer of the Cryotop vitrification method, the most widely used oocyte and embryo cryopreservation system globally. Direct competitor in ART cryopreservation consumables with similar target customers and product category.
• Genea Biomedx: Australian-based ART device and consumables company offering products including vitrification tools for fertility clinics. Direct competitor targeting the same embryologist customer base with workflow-focused ART solutions.
• Vitrolife: Swedish IVF media and cryopreservation solutions provider serving fertility clinics worldwide. Competes directly with Cryotec in vitrification and warming media for oocytes and embryos, with a broader portfolio across the IVF workflow.
• Gynemed: German manufacturer of ART media and cryopreservation solutions for IVF clinics. Direct competitor offering comparable vitrification and warming products to the same embryologist customer segment, particularly strong in Europe.
• LifeGlobal Group: Provider of IVF media, including vitrification solutions, sold to fertility clinics worldwide. Competes directly with Cryotec in oocyte and embryo cryopreservation media, with comparable single-use kit offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC4d7HBb8-sAwlwMKij5Kn0Q
• Facebookfacebook.com/Cryotec.Reprolife
• LinkedInlinkedin.com/company/reprolife-cryotec
• Instagraminstagram.com/cryotec.global
• TikToktiktok.com/@cryotecglobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryotec Global